Peuchmaur M, Emilie D, Crevon M C, Solal-Celigny P, Maillot M C, Lemaigre G, Galanaud P
INSERM U 131, Hôpital Antoine Béclère, Clamart, France.
Am J Pathol. 1990 Feb;136(2):383-90.
Expression of the IL-2 receptor (Tac antigen/CD25) is documented in malignant lymphomas. Because IL-2 is a major lymphocyte growth factor, an IL-2-dependent growth could be involved in the proliferation of Tac-positive lymphomas. Indeed such a mechanism has been demonstrated experimentally for the growth of T-cell lines. To investigate this point in human lymphomas, we used in situ hybridization to analyze the expression of the IL-2 gene in 20 non-Hodgkin's lymphomas, among which 12 expressed the IL-2 receptor. Nine of these were anaplastic large cell lymphomas expressing the Ki-1-related antigen. We here show that IL-2-producing cells are present in all the lymphomas we analyzed. As a mean, there is no significant difference in the percentage of IL-2-producing cells between Tac-positive and -negative lymphomas. However, the level of IL-2 production is highly heterogeneous in both groups, and the highest density of IL-2-producing cells was observed in 2 Tac-positive lymphomas. Simultaneous detection of cellular antigens and of IL-2 mRNA demonstrates that IL-2 is produced by reactive T cells rather than by tumor cells. These results suggest that if IL-2 is involved in the growth of Tac-positive lymphomas, it acts as a paracrine, rather than an autocrine, factor.
白细胞介素-2受体(Tac抗原/CD25)在恶性淋巴瘤中的表达已有文献记载。由于白细胞介素-2是一种主要的淋巴细胞生长因子,白细胞介素-2依赖的生长可能参与了Tac阳性淋巴瘤的增殖。事实上,这种机制已在T细胞系的生长实验中得到证实。为了在人类淋巴瘤中研究这一点,我们使用原位杂交技术分析了20例非霍奇金淋巴瘤中白细胞介素-2基因的表达,其中12例表达白细胞介素-2受体。这些病例中有9例是表达Ki-1相关抗原的间变性大细胞淋巴瘤。我们在此表明,在我们分析的所有淋巴瘤中都存在产生白细胞介素-2的细胞。平均而言,Tac阳性和阴性淋巴瘤之间产生白细胞介素-2的细胞百分比没有显著差异。然而,两组中白细胞介素-2的产生水平高度异质性,在2例Tac阳性淋巴瘤中观察到产生白细胞介素-2的细胞的最高密度。细胞抗原和白细胞介素-2 mRNA的同时检测表明,白细胞介素-2是由反应性T细胞而非肿瘤细胞产生的。这些结果表明,如果白细胞介素-2参与Tac阳性淋巴瘤的生长,它作为旁分泌因子而非自分泌因子发挥作用。